Kymera Therapeutics, Inc. (KYMR)
115.10
-1.90
(-1.62%)
USD |
NASDAQ |
Sep 11, 16:00
115.10
0.00 (0.00%)
After-Hours: 17:08
Kymera Therapeutics Gross Profit (TTM) : 96.77M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 96.77M |
| March 31, 2026 | 43.19M |
| December 31, 2025 | 30.90M |
| September 30, 2025 | 35.48M |
| June 30, 2025 | 36.61M |
| March 31, 2025 | 50.96M |
| December 31, 2024 | 39.70M |
| September 30, 2024 | 81.30M |
| June 30, 2024 | 83.38M |
| March 31, 2024 | 75.25M |
| December 31, 2023 | 75.03M |
| September 30, 2023 | 43.33M |
| June 30, 2023 | 48.25M |
| March 31, 2023 | 43.45M |
| Date | Value |
|---|---|
| December 31, 2022 | 43.81M |
| September 30, 2022 | 43.07M |
| June 30, 2022 | 34.32M |
| March 31, 2022 | 23.51M |
| December 31, 2021 | 14.59M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 1.472M |
| June 30, 2020 | 1.472M |
| March 31, 2020 | 1.472M |
| December 31, 2019 | 1.472M |
| September 30, 2019 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Oncolytics Biotech, Inc. | -0.11M |
| Sangamo Therapeutics, Inc. | 28.00M |
| Sarepta Therapeutics, Inc. | 1.117B |
| Anixa Biosciences, Inc. | -0.039M |